Globus Stock Analysis

GMED
 Stock
  

USD 67.06  0.48  0.71%   

The latest indifference towards the small price fluctuations of Globus Medical may raise some interest from shareholders. The stock closed today at a share price of 67.06 on 431,399 in trading volume. The company directors and management did not add any value to Globus Medical investors in July. However, most investors can still diversify their portfolios with Globus Medical to hedge their inherited risk against high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 2.16. The current volatility is consistent with the ongoing market swings in July 2022 as well as with Globus Medical unsystematic, company-specific events.
Please check Risk vs Return Analysis.
  
The Globus Medical stock analysis report makes it easy to digest most publicly released information about Globus Medical and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Globus Stock analysis module also helps to analyze the Globus Medical price relationship with some important fundamental indicators such as market cap and management efficiency.

Globus Stock Analysis Notes

About 76.0% of the company shares are owned by institutional investors. The book value of Globus Medical was currently reported as 17.08. The company had not issued any dividends in recent years. Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania. Globus Medical operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 2400 people. To learn more about Globus Medical call David Paul at 302 636-5454 or check out www.globusmedical.com.

Globus Medical Quarterly Cost of Revenue

68.47 Million

Globus Medical Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Globus Medical's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Globus Medical or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Globus Medical has high likelihood to experience some financial distress in the next 2 years
Over 76.0% of the company shares are owned by institutional investors
Latest headline from www.marketbeat.com: Globus Medical Price Target Cut to 71.00 - MarketBeat

Globus Medical Upcoming and Recent Events

Earnings reports are used by Globus Medical to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Globus Medical previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report16th of February 2022
Next Financial Report3rd of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End16th of February 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Globus Largest EPS Surprises

Earnings surprises can significantly impact Globus Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2015-11-03
2015-09-300.250.280.0312 
2014-10-30
2014-09-300.210.240.0314 
2014-02-26
2013-12-310.220.250.0313 
View All Earnings Estimates

Globus Medical SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Globus Medical prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Globus Medical investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Globus Medical specific information freely available to individual and institutional investors to make a timely investment decision.
4th of August 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
3rd of June 2022
Financial Statements and Exhibits. Submission of Matters to a Vote of Security Holders. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
10th of May 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
21st of April 2022
Financial Statements and Exhibits. Regulation FD Disclosure. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Results of Operations and Financial Condition
View
4th of March 2022
Financial Statements and Exhibits. Other Events
View
17th of February 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
10th of February 2022
Unclassified Corporate Event
View
9th of February 2022
Unclassified Corporate Event
View

Globus Medical Thematic Classifications

In addition to having Globus Medical stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Baby Boomer Prospects
Mega stocks, funds and ETFs that tend to appeal to people considering retirement from the work force
Medical Equipment
USA Equities from Medical Equipment industry as classified by Fama & French
Obamacare Repeal
Large healthcare related equities associated with Obamacare
Obamacare
Companies that count on Obamacare to take off

Globus Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Globus Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Globus Medical backward and forwards among themselves. Globus Medical's institutional investor refers to the entity that pools money to purchase Globus Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Vanguard Group IncCommon Shares7.5 M418.8 M
Blackrock IncCommon Shares7.5 M418.5 M
Janus Henderson Group PlcCommon Shares6.7 M376.1 M
Kayne Anderson Rudnick Investment Management LlcCommon Shares4.6 M256.2 M
Wellington Management Group LlpCommon Shares3.5 M193.8 M
State Street CorpCommon Shares2.2 M123.3 M
Invesco LtdCommon Shares1.9 M106.1 M
Note, although Globus Medical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Globus Market Capitalization

The company currently falls under 'Mid-Cap' category with current market capitalization of 6.5 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Globus Medical's market, we take the total number of its shares issued and multiply it by Globus Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Globus Profitablity

Globus Medical's profitability indicators refer to fundamental financial ratios that showcase Globus Medical's ability to generate income relative to its revenue or operating costs. If, let's say, Globus Medical is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Globus Medical's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Globus Medical's profitability requires more research than a typical breakdown of Globus Medical's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 15.91 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 27.02 %, which suggests for every 100 dollars of sales, it generated a net operating income of 0.27.
Last ReportedProjected for 2022
Return on Investment 10.59  10.87 
Return on Average Assets 0.08  0.09 
Return on Average Equity 0.09  0.11 
Return on Invested Capital 0.14  0.21 
Return on Sales 0.18  0.20 

Management Efficiency

The entity has return on total asset (ROA) of 6.53 % which means that it generated profit of $6.53 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 9.28 %, meaning that it created $9.28 on every $100 dollars invested by stockholders. Globus Medical management efficiency ratios could be used to measure how well globus medical manages its routine affairs as well as how well it operates its assets and liabilities. The current year Return on Investment is expected to grow to 10.87. The current year Return on Average Assets is expected to grow to 0.09. Globus Medical Tax Assets are projected to decrease significantly based on the last few years of reporting. The past year's Tax Assets were at 25.71 Million. The current year Revenue to Assets is expected to grow to 0.66, whereas Current Assets are forecasted to decline to about 780.7 M.
Last ReportedProjected for 2022
Book Value per Share 17.29  14.57 
Enterprise Value over EBIT 41.00  35.71 
Enterprise Value over EBITDA 28.90  25.94 
Price to Book Value 4.21  4.37 
Tangible Assets Book Value per Share 16.96  14.24 
Enterprise ValueB5.8 B
Tangible Asset Value1.7 B1.4 B

Technical Drivers

As of the 16th of August 2022, Globus Medical retains the Market Risk Adjusted Performance of 0.1967, risk adjusted performance of 0.1109, and Downside Deviation of 2.06. Globus Medical technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for Globus Medical, which can be compared to its competitors. Please check out Globus Medical value at risk, and the relationship between the jensen alpha and semi variance to decide if Globus Medical is priced fairly, providing market reflects its last-minute price of 67.06 per share. Given that Globus Medical has jensen alpha of 0.0895, we strongly advise you to confirm Globus Medical's regular market performance to make sure the company can sustain itself at a future point.

Globus Medical Price Movement Analysis

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. Globus Medical Triple Exponential Moving Average indicator shows smoothing effect of Globus Medical price series composite of a single exponential moving average, a double exponential moving average and a triple exponential moving average.
.

Globus Medical Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Globus Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Globus Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Globus Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Keith Pfeil over a week ago via Macroaxis 
Exercise or conversion by Keith Pfeil of 833 shares of Globus Medical subject to Rule 16b-3
Kelly Huller over three months ago via Macroaxis 
Exercise or conversion by Kelly Huller of 2500 shares of Globus Medical subject to Rule 16b-3
Kelly Huller over three months ago via Macroaxis 
Exercise or conversion by Kelly Huller of 2500 shares of Globus Medical subject to Rule 16b-3
James Tobin over three months ago via Macroaxis 
Exercise or conversion by James Tobin of 3542 shares of Globus Medical subject to Rule 16b-3
James Tobin over three months ago via Macroaxis 
Exercise or conversion by James Tobin of 10000 shares of Globus Medical subject to Rule 16b-3
David Davidar over six months ago via Macroaxis 
Globus Medical exotic insider transaction detected
Kelly Huller over six months ago via Macroaxis 
Acquisition by Kelly Huller of 30000 shares of Globus Medical subject to Rule 16b-3
David Demski over six months ago via Macroaxis 
Exercise or conversion by David Demski of 7053 shares of Globus Medical subject to Rule 16b-3
Keith Pfeil over six months ago via Macroaxis 
Exercise or conversion by Keith Pfeil of 833 shares of Globus Medical subject to Rule 16b-3
Keith Pfeil over a year ago via Macroaxis 
Exercise or conversion by Keith Pfeil of 833 shares of Globus Medical subject to Rule 16b-3
Keith Pfeil over a year ago via Macroaxis 
Exercise or conversion by Keith Pfeil of 834 shares of Globus Medical subject to Rule 16b-3
Daniel Scavilla over a year ago via Macroaxis 
Exercise or conversion by Daniel Scavilla of 50000 shares of Globus Medical subject to Rule 16b-3

Globus Medical Predictive Daily Indicators

Globus Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Globus Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Globus Medical Forecast Models

Globus Medical time-series forecasting models is one of many Globus Medical's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Globus Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Globus Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Globus Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Globus shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Globus Medical. By using and applying Globus Stock analysis, traders can create a robust methodology for identifying Globus entry and exit points for their positions.
Last ReportedProjected for 2022
Operating Margin 17.95  24.12 
EBITDA Margin 0.25  0.26 
Gross Margin 0.75  0.72 
Profit Margin 0.16  0.16 
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania. Globus Medical operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 2400 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Globus Medical to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Portfolio File Import Now

   

Portfolio File Import

Quickly import all of your third-party portfolios from your local drive in csv format
All  Next Launch Module
Please check Risk vs Return Analysis. Note that the Globus Medical information on this page should be used as a complementary analysis to other Globus Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Complementary Tools for Globus Stock analysis

When running Globus Medical price analysis, check to measure Globus Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Globus Medical is operating at the current time. Most of Globus Medical's value examination focuses on studying past and present price action to predict the probability of Globus Medical's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Globus Medical's price. Additionally, you may evaluate how the addition of Globus Medical to your portfolios can decrease your overall portfolio volatility.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Is Globus Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Globus Medical. If investors know Globus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Globus Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.33
Market Capitalization
6.6 B
Quarterly Revenue Growth YOY
0.05
Return On Assets
0.0653
Return On Equity
0.0929
The market value of Globus Medical is measured differently than its book value, which is the value of Globus that is recorded on the company's balance sheet. Investors also form their own opinion of Globus Medical's value that differs from its market value or its book value, called intrinsic value, which is Globus Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Globus Medical's market value can be influenced by many factors that don't directly affect Globus Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Globus Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine Globus Medical value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Globus Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.